Analysis - Page 1
Stay up to date with the latest Analysis updates from the global pharmaceutical industryLatest Analysis Update
Ahead in the cloud – a new home for clinical trial data As the volume and complexity of clinical trial data grows, scientists need new ways to filter information. Elly Earls speaks to SAFE Bio-Pharma's Mollie Shields-Uehling and IBM's Chris Hines...
Taking aim with nanotechnology One of the key challenges of drug delivery is ensuring the right dose reaches the target without damaging healthy cells. Richard Moore of the Institute of Nanotechnology and inventor,...
API compliance – safeguarding the supply chain In the war against fake medicines, protecting the upstream supply chain will be a decisive battle. Dr Gareth Evans reports on how the Council of the European Union's initial formal adoption of...
Calling on contract manufacturing Outsourcing the pharmaceutical pipeline has become a popular option for companies big and small. Frances Cook talks to leading contract developer and manufacturer of pharmaceuticals Aesica...
Mighty materials: the challenges of developing potent APIs What solutions are available for producing increasingly powerful active pharmaceutical ingredients? Sarah Blackman talks to Stuart Needleman of Aptuit about the manufacturing methods used to...
Snapshot: Prostate Cancer - Global Drug Forecasts and Treatment Analysis Prostate cancer is the most common form of the disease in men but as yet, no one-size fits all treatment is available. Using detailed GlobalData research this market snapshot analyses the...
The Need for Speed: Imaging Biomarkers in Clinical Trials Imaging biomarkers could hold the key to faster, more cost-effective drug development if used properly. Chris Lo speaks to Clinical Trials Network chairman Dr Michael Graham to find out more...
Snapshot: Coronary Artery Disease Global Clinical Trials 2011 An estimated 17 million people die of coronary artery disease worldwide every year, and numbers are rising. While pharmaceutical efforts to find a cure have always been fiercely competitive,...
Snapshot: Respiration Disorders Global Clinical Trials Major trials are underway for treatments of respiration disorder, the second biggest cause of death worldwide. As pollution levels increase and disorders become more likely, the race to treat...
Snapshot: Global Pain Clinical Trials Q1 2011 The global pain market is a moderately growing market with huge potential for growth. A number of patent expiries in the near future could provide more twists in the tale, but are we any closer...